These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8798624)

  • 21. Lymphocyte function-associated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM subfamily.
    Casasnovas JM; Pieroni C; Springer TA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3017-22. PubMed ID: 10077629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1).
    McDowall A; Leitinger B; Stanley P; Bates PA; Randi AM; Hogg N
    J Biol Chem; 1998 Oct; 273(42):27396-403. PubMed ID: 9765268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel LFA-1 activation epitope maps to the I domain.
    Landis RC; Bennett RI; Hogg N
    J Cell Biol; 1993 Mar; 120(6):1519-27. PubMed ID: 7680657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
    Huth JR; Olejniczak ET; Mendoza R; Liang H; Harris EA; Lupher ML; Wilson AE; Fesik SW; Staunton DE
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5231-6. PubMed ID: 10805782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.
    Diamond MS; Staunton DE; Marlin SD; Springer TA
    Cell; 1991 Jun; 65(6):961-71. PubMed ID: 1675157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.
    Cabañas C; Hogg N
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5838-42. PubMed ID: 7685913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow.
    Knorr R; Dustin ML
    J Exp Med; 1997 Aug; 186(5):719-30. PubMed ID: 9271587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
    Stanley P; McDowall A; Bates PA; Brashaw J; Hogg N
    Biochem J; 2000 Oct; 351(Pt 1):79-86. PubMed ID: 10998349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
    Pyszniak AM; Carpenito C; Takei F
    Exp Cell Res; 1997 May; 233(1):78-87. PubMed ID: 9184078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1.
    Staunton DE; Dustin ML; Springer TA
    Nature; 1989 May; 339(6219):61-4. PubMed ID: 2497351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion.
    Li R; Nortamo P; Valmu L; Tolvanen M; Huuskonen J; Kantor C; Gahmberg CG
    J Biol Chem; 1993 Aug; 268(23):17513-8. PubMed ID: 8349630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel cyclic peptide inhibits intercellular adhesion molecule-1-mediated cell aggregation.
    Shannon JP; Silva MV; Brown DC; Larson RS
    J Pept Res; 2001 Aug; 58(2):140-50. PubMed ID: 11532073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes.
    Fawcett J; Holness CL; Needham LA; Turley H; Gatter KC; Mason DY; Simmons DL
    Nature; 1992 Dec; 360(6403):481-4. PubMed ID: 1448173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.
    Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4140-5. PubMed ID: 9539703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct.
    Driessens MH; van Hulten P; Zuurbier A; La Rivière G; Roos E
    J Leukoc Biol; 1996 Dec; 60(6):758-65. PubMed ID: 8975879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase.
    Arroyo AG; Campanero MR; Sánchez-Mateos P; Zapata JM; Ursa MA; del Pozo MA; Sánchez-Madrid F
    J Cell Biol; 1994 Sep; 126(5):1277-86. PubMed ID: 7520448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging.
    Duperray A; Languino LR; Plescia J; McDowall A; Hogg N; Craig AG; Berendt AR; Altieri DC
    J Biol Chem; 1997 Jan; 272(1):435-41. PubMed ID: 8995280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of lymphocyte function-associated molecule-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) mimicked by an antibody directed against CD18.
    Petruzzelli L; Maduzia L; Springer TA
    J Immunol; 1995 Jul; 155(2):854-66. PubMed ID: 7608563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1.
    Binnerts ME; van Kooyk Y; Simmons DL; Figdor CG
    Eur J Immunol; 1994 Sep; 24(9):2155-60. PubMed ID: 7916295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes.
    Hernandez-Caselles T; Rubio G; Campanero MR; del Pozo MA; Muro M; Sanchez-Madrid F; Aparicio P
    Eur J Immunol; 1993 Nov; 23(11):2799-806. PubMed ID: 8223855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.